Mucin overproduction in chronic inflammatory lung disease

Canadian Respiratory Journal

Volumn 13, Issue 6, 2006, Pages 327-335

  Hauber, Hans Peter ^a,b   Foley, Susan C ^a   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Bacteria; Cytokine; Lung; Mucin; Neutrophil elastase; Overproduction; Smoke

Indexed keywords

CYTOKINE; GROWTH FACTOR; LEUKOCYTE ELASTASE; MUCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BORDETELLA PERTUSSIS; BRONCHUS MUCUS; CYTOKINE PRODUCTION; ENZYME INDUCTION; GENE EXPRESSION; GENE IDENTIFICATION; HAEMOPHILUS INFLUENZAE; HUMAN; LUNG DISEASE; MUCUS SECRETION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; PSEUDOMONAS AERUGINOSA; REVIEW; SMOKE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; UPREGULATION;

EID: 33750182181     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/901417     Document Type: Review

References (153)

1. Perez-Vilar J, Sheehan JK, Randell SH. Making more MUCS. Am J Respir Cell Mol Biol 2003;28:267-70.
2. Litt M, Khan MA, Chakrin LW, Wardell P Jr, Christian P. The viscoelasticiry of fractionated canine tracheal mucus. Biorheology 1974;11:111-7.
3. Perks B, Shute JK. DNA and actin bind and inhibit interleukin-8 function in cystic fibrosis sputa: In vitro effects of mucolytics. Am J Respir Crit Care Med 2000;162:1767-72.
4. Tang JX, Wen Q, Bennett A, et al. Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol 2005;289:L599-605.
5. Lamblin G, Aubert JP, Perini JM, et al. Human respiratory mucins. Eur Respir J 1992;5:247-56.
6. Rose MC. Mucins: Structure, function, and role in pulmonary diseases. Am J Physiol 1992;263:L413-29.
7. Rose MC, Gendler SJ. Airway mucin genes and gene products. In: Rogers DF, Lethem MI, eds. Airway Mucus: Basic Mechanisms and Clinical Perspectives. Boston: Birkhauser Verlag, 1997:41-66.
8. Strous GJ, Dekker J. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 1992;27:57-92.
9. Verma M, Davidson EA. Mucin genes: Structure, expression and regulation. Glycoconj J 1994;11:172-9.
10. Woodward H, Horsey B, Bhavandan VP, Davidson EA. Isolation, purification, and properties of respiratory mucus glycoproteins. Biochemistry 1982;21:694-701.
11. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats J Biol Chem 1988;263:12820-3.
12. Porchet N, Nguyen VC, Dufosse J, et al. Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Common 1991;175:414-22.
13. Pratt WS, Islam I, Swallow DM. Two additional polymorphisms within the hypervariable MUC1 gene: Association of alleles either side of the VNTR region. Ann Hum Genet 1996;60:21-8.
14. Shankar V, Gilmore MS, Elkins RC, Sachdev GP. A novel human airway mucin cDNA encodes a protein with unique tandem-repeat organization. Biochem J 1994;300:295-8.
15. Borchers MT, Carty MP, Leikauf GD. Regulation of human airway mucins by acrolein and inflammatory mediators. Am J Physiol 1999;276:L549-55.
16. Serengi E, Botti C, Massaron S, et al. Structure, function and gene expression of epithelial mucins. Tumori 1997;83:625-32.
17. Mandel U, Hassan H, Therkildsen MH, et al. Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: Immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology 1999;9:43-52.
18. Kingsley PD, Hagen KG, Maltby KM, Zara J, Tabak LA. Diverse spatial expression patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyl-transferase family member mRNAs during mouse development. Glycobiology 2000;10:1317-23.
19. Spicer AP, Parry G, Patton S, Gendler SJ. Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism. J Biol Chem 1991;266:15099-109.
20. Gum JR Jr, Hicks JW, Toribara NW, Siddiki B, Kim YS. Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem 1994;269:2440-6.
21. Van Kliniken BJ, Van Dijken TC, Oussoren E, Buller HA, Dekker J, Einerhand AW. Molecular cloning of human MUC3 cDNA reveals a novel 59 amino acid tandem repeat region. Biochem Biophys Res Commun 1997;238:143-8.
22. Moniaux N, Nollet S, Porchet N, Degand P, Laine A, Aubert JP. Complete sequence of the human mucin MUC4: A putative cell membrane-associated mucin. Biochem J 1999;338:325-33.
23. Van de Bovenkamp JH, Hau CM, Strous GJ, Buller HA, Dekker J, Einerhand AW. Molecular cloning of human gastric mucin MUC5AC reveals conserved cysteine-rich D-domains and a putative leucine zipper motif. Biochem Biophys Res Commun 1998;245:853-9.
24. Keates AC, Nunes DP, Afdhal NH, Troxler RF, Offner GD. Molecular cloning of a major human gall bladder mucin: Complete C-terminal sequence and genomic organization of MUC5B. Biochem J 1997;324:295-303.
25. Ho SB, Roberton AM, Shekels LL, Lyftogt CT, Niehans GA, Toribara NW. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 1995;109:735-47.
26. Bobek LA, Tsai H, Biesbrock AR, Levine MJ. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem 1993;268:20563-9.
27. Shankar V, Pichan P, Eddy RL Jr, et al. Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol 1997;16:232-41.
28. Lapensee L, Paquette Y, Bleau G. Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil Steril 1997;68:702-8.
29. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999;59:4083-9.
30. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. MUC13, a novel human cell surface mucin expressed by epithelial and hematopoetic cells. J Biol Chem 2001;276:18327-36.
31. Pallesen LT, Berglund L, Rasmussen LK, Petersen TE, Rasmussen JT. Isolation and characterization of MUC15, a novel cell membrane-associated mucin. Eur J Biochem 2002;269:2755-63.
32. Yin BW, Llyod KO. Molecular cloning of the CA125 ovarian cancer antigen: Identification as a new mucin, MUC16. J Biol Chem 2001;276:27371-5.
33. Gum JR Jr, Crawley SC, Hicks JW, Szymkowski DE, Kim YS. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 2002;291:466-75.
34. Sers C, Kirsch K, Rothbacher U, Riethmuller G, Johnson JP. Genomic organization of the melanoma-associated glycoprotein MUC18: Implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci USA 1993;90:8514-8.
35. Chen Y, Zhao YH, Kalaslavadi TB, et al. Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol 2004;30:155-65.
36. Higuchi T, Orita T, Nakanishi S, et al. Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem 2004;279:1968-79.
37. Fox MF, Lahbib F, Pratt W. Regional localization of the intestinal mucin gene MUC3 to chromosome 7q22. Ann Hum Genet 1992;56:281-7.
38. Pigny P, Guyonnet-Duperat V, Hill AS, et al. Human mucin genes assigned to 11p15.5: Identification and organization of a cluster of genes. Genomics 1996;38:340-52.
39. Velcich A, Palumbo L, Selleri L, Evans G, Augenlicht L. Organization and regulatory aspects of the human intestinal mucin gene (MUC2) locus. J Biol Chem 1997;272:7968-76.
40. Li D, Gallup M, Fan N, Szymkowski DE, Basbaum CB. Cloning of the amino-terminal and 5′-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J Biol Chem 1998;273:6812-20.
41. Van Seuningen I, Perrais M, Pigny P, Porchet N, Aubert JP. Sequence of the 5′-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells. Biochem J 2000;348:675-86.
42. Welsh Mj, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases. New York: McGraw-Hill, 1995:3799-876.
43. Senior RM, Shapiro SD. Chronic obstructive pulmonary disease: Epidemiology, pathophysiology, and pathogenesis. In: Fishman AP, ed. Fishman's Pulmonary Diseases and Disorders. New York: McGraw-Hill, 1998:659-81.
44. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51:267-71.
45. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994;150:448-54. (Erratum in 1995;151:260).
46. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso F, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-82.
47. Amitani R, Wilson R, Rutman A, et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol 1991;4:26-32.
48. Kim KC, Wasano K, Niles RM, Schuster JE, Stone PJ, Brody JS. Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells. Proc Natl Acad Sci USA 1987;84:9304-8.
49. Fahy JV, Schuster A, Ueki I, Boushey HA, Nadel JA. Mucus hypersecretion in bronchiectasis. The role of nentrophil proteases. Am Rev Respir Dis 1992;146:1430-3.
50. Lundgren JD, Rieves RD, Mullol J, Logun C, Shelhammer JH. The effect of neutrophil protenase enzymes on the release of mucus from feline and human airway cultures. Respir Med 1994;88:511-8.
51. Breuer R, Christensen TG, Lucey EC, Stone PJ, Snider GL. An ultrastructural morphometric analysis of elastase-treated hamster bronchi shows discharge followed by progressive accumulation of secretory granules. Am Rev Respir Dis 1987;136:698-703.
52. Voynow JA, Young LR, Wang Y, Horger T, Rose MC, Fischer BM. Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 1999;276:L835-43.
53. Fischer B, Voynow J. Neutrophil elastase induces MUC5AC messenger RNA expression by an oxidant-dependent mechanism. Chest 2000;11 7(Suppl 1):317S-20S.
54. Fischer BM, Voynow JA. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol 2002;26:447-52.
55. Kohri K, Ueki IF, Nadel JA. Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol 2002;283:L531-40.
56. Kuroki M, Voest EE, Amano S, et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996;98:1667-75.
57. waf1/cip1 expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway. Eur J Biochem 1997;245:730-7.
58. Shao MX, Nadel JA. Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 2005;102:767-72.
59. Babior BM. The respiratory burst oxidase. Curr Opin Hematol 1995;2:55-60.
60. Geiszt M, Witta J, Baffi J, Lekstrom K, Leto TL. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 2003;17:1502-4.
61. Li JD, Dohrman AF, Gallup M, et al. Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci USA 1997;94:967-72.
62. McNamara N, Basbaum C. Signaling networks controlling mucin production in response to Gram-positive and Gram-negative bacteria. Glycoconi J 2001;18:715-22.
63. Li JD, Feng W, Gallup M, et al. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci USA 1998;95:5718-23.
64. Feldman M, Bryan R, Rajan S, et al. Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 1998;66:43-51.
65. McNamara N, Khong A, McKemy D, et al. ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor. Proc Natl Acad Sci USA 2001;98:9086-91.
66. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993;361:315-25.
67. Salyers AA, Whitt DD. Bacterial Pathogenesis: A Molecular Approach. Washington, DC: ASM Press, 1994:341.
68. Lemjabbar H, Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat Med 2002;8:41-6.
69. Cundell D, Gerard N, Gerard C, Idanpaan-Heikkila I, Tuomanen E. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995;377:435-8.
70. Cundell DR, Gerard C, Idanpaan-Heikkila I, Tuomanen EI, Gerard NP. PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv Exp Med Biol 1996;416:89-94.
71. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996;379:557-60.
72. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999;402:884-8.
73. Maudsley S, Pierce KL, Zamah AM, et al. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 2000;275:9572-80.
74. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning C. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-9.
75. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999;11:443-51.
76. Michelsen K, Aicher A, Mohaupt M, et al. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCs). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 2001;276:25680-6.
77. Opitz B, Schroder N, Spreitzer I, et al. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J Biol Chem 2001;276:22041-7.
78. Dohrman A, Miyata S, Gallup M, et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta 1998;1406:251-9.
79. Groneberg DA, Eynott PR, Oates T, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Resp Med 2002;96:81-6.
80. Kohri K, Ueki IF, Shim JJ, et al. Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor. Eur Respir J 2002;20:1263-70.
81. Moxon ER. The carrier state: Haemophilus influenzae. J Antimicrob Chemother 1986;18(Suppl A):17-24.
82. Wang B, Lim DJ, Han J, Kim YS, Basbaum CB, Li JD. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphomositide 3-kinase-Akt pathway. J Biol Chem 2002;277:949-57.
83. Jono H, Xu H, Kai H, et al. Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. J Biol Chem 2003;278:27811-9.
84. Belcher CE, Drenkow J, Kehoe B, et al. The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies. Proc Natl Acad Sci USA 2000;97:13847-52.
85. Henke MO, Renner A, Huber RM, Seeds MC, Rubin BK. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Mol Cell Biol 2004;31:86-91.
86. Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162:6233-7.
87. Temann UA, Prasad B, Gallup MW, et al. A novel role for murine IL-4 in vivo: Induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 1997;16:471-8.
88. Kotsimbos TC, Ernst P, Hamid QA. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc Assoc Am Physicians 1996;108:368-73.
89. Humbert M, Durham SR, Kimmitt P, et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-65.
90. de Vries J. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998;102:165-9.
91. Murata T, Taguchi J, Puri RK. Interleukin-13 receptor alpha′ but not alpha chain: A functional component of interleukin-4 receptors. Blood 1998;91:3884-91.
92. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-88.
93. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258-61.
94. Grünig G, Warnock M, Wakil AE, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-3.
95. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998;187:939-48.
96. Mullings RE, Wilson SJ, Puddicombe SM, et al. Signal transducer and activator of transrciption 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol 2001;108:832-8.
97. Kuperman DA, Huang X, Koth LL, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002;8:885-9.
98. Whittaker L, Niu N, Temann UA, et al. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol 2002;27:593-602.
99. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001;2:45-50.
100. Cohn L, Homer RJ, MacLeod H, Mohrs M, Brombacher F, BoLtomly K. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol 1999;162:6178-83.
101. Shimbara A, Christodoupoulos P, Soussi-Gounni A, et al. IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthma. J Allergy Clin Immunol 1999;104:108-15.
102. Longphre M, Li D, Gallup M, et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999;104;1375-82.
103. Louahed J, Toda M, Jeri J, et al. Interteukin-9 upregutates mucus expression in the airways. Am J Respir Cell Mol Biol 2000;22:649-56.
104. Kung TT, Lou B, Crawley Y, et al. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol 2001;25:600-5.
105. Nakanishi A, Morita S, Iwashita H, et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001;98:5175-80.
106. Zhou Y, Dong Q, Louahed J, et al. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol 2001;25:486-91.
107. Toda M, Tulic MK, Levitt RC, Hamid Q. A calcium-activated chloride channel (hCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol 2002;109:246-50.
108. Hauber HP, Tsicopoulos A, Wallaert B, et al. Expression of hCLCA1 in cystic fibrosis lungs is associated with mucus overproduction. Eur Respir J 2004;23:846-50.
109. Hauber HP, Bergeron C, Tsicopoulos A, et al. Increased expression of the calcium-activated chloride channel in hCLCA1 in airways of patients with obstructive chronic bronchitis. Can Respir J 2005;12:143-6.
110. Gibson A, Lewis AP, Affleck K, Meldrum E, Thompson N. hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channels. J Biol Chem 2005;280:27205-12.
111. Hauber HP, Daigneault P, Frenkiel S, et al. Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J Allergy Clin Immunol 2005;115:266-71.
112. Vermeer PA, Harson R, Einwalter LA, Moninger T, Zabner J. Interleukin-9 induces goblet cell hyperplasia during the repair of human airway epithelia. Am J Respir Cell Mol Biol 2003;28:286-95.
113. Kim CH, Song KS, Koo JS, et al. IL-13 suppresses MUC5AC gene expression and mucin secretion in nasal epithelial cells. Acta Otolaryngol 2002;122:638-43.
114. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/ autocrine loop. J Biol Chem 2003;278:17036-43.
115. Seong JK, Koo JS, Lee WJ, et al. Upregulation of MUC8 and downregulation of MUC5AC by inflammatory mediators in human nasal polyps and cultured nasal epithelium. Acta Otolaryngol 2002;122:401-7.
116. Jayawickreme SP, Gray T, Nettesheim P, Eling T. Regulation of 15-lipooxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells. Am J Physiol 1999;276:L596-603.
117. Cohan VL, Scott AL, Dinarello CA, Prendergast RA. Interleukin-1 is a mucus secretagogue. Cell Immunol 1991;136:425-34.
118. Kim YD, Kwon EJ, Kwon TK, Baek SH, Song SY, Suj JS. Regulation of IL-1 beta mediated MUC2 gene in NCI-H292 human airway epithelial cells. Biochem Biophys Res Commun 2000;274:112-16.
119. Lee JJ, McGarry MP, Denzler KL, et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:2143-56.
120. Levine SJ, Larivee P, Logun C, Angus CW, Ognibene FP, Shelhamer JH. Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol 1995;12:196-204.
121. Lee CG, Homer RJ, Cohn L, et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 2002;277:35466-74.
122. Song KS, Lee WJ, Chung KC, et al. Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J Biol Chem 2003;278:23243-50.
123. Perrais M, Pigny P, Copin MC, Aubert JP, Van Seuningen I. Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Spl. J Biol Chem 2002;277:32258-67.
124. Mueller TD, Zhang JL, Sebald W, Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta 2002;1592:237-50.
125. Murata T, Taguchi J, Puri RK, Mohri H. Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system. Int J Hematol 1999;69:13-20.
126. Demoulin JB, Renauld JC. Interleukin 9 and its receptor: An overview of structure and function. Int Rev Immunol 1998;16:345-64.
127. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: The signal orchestration model. Rev Physiol Biochem Pharmacol 2003;149:1-38.
128. Davies DE, Polosa R, Puddicombe SM, Richter A, Holgate ST. The epidermal growth factor receptor and its ligand family: Their potential role in repair and remodeling in asthma. Allergy 1999;54:771-83.
129. Takeyama K, Dabbagh K, Lee HM, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 1999;96:3081-6.
130. Peschon JJ, Slack JL, Reddy P, et al. An essential role for ectodomain shedding in mammalian development. Science 1998;282:1281-4.
131. Shao MX, Ueki IF, Nadel JA. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 2003;100:11618-23.
132. Gonzalez-Guerrico AM, Cafferata EG, Radrizzani M, et al. Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis. J Biol Chem 2002;19:17239-47.
133. Mohler PJ, Kreda SM, Boucher RC, Sudol M, Stints MJ, Milgram SL. Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50. J Cell Biol 1999;147:879-90.
134. Moyer BD, Denton J, Karlson KH, et al. A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest 1999;104:1353-61.
135. Fischer H, Machen TE. The tyrosine kinase p60c-src regulates the fast gate of the cystic fibrosis transmembrane conductance regulator chloride channel. Biophys J 1996;71:3073-82.
136. Li Y, Ren J, Yu W, et al. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem 2001;276:35239-42.
137. Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Scr tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3beta and beta-caenin. J Biol Chem 2001;276:6061-4.
138. Leikauf GD. Mechanisms of aldehyde-induced bronchial reactivity: Role of airway epithelium. Res Rep Health Eff Inst 1992;49:1-35.
139. US Environmental Protection Agency. Toxics in the Community: National and Local Perspectives. Washington, DC: US Environmental Protection Agency, 1991.
140. Borchers MT, Wert SE, Leikauf GD. Acrolein-induced MUC5AC expression in rat airways. Am J Physiol 1998;274:L573-81.
141. Leikauf GD, Leming LM, O'Donnell JR, Doupnik CA. Bronchial responsiveness and inflammation in guinea pigs exposed to acrolein. J Appl Physiol 1989;66:171-8.
142. Kutzman RS, Popenoe EA, Schmaeler M, Drew RT. Changes in rat lung structure and composition as a result of subchronic exposure to acrolein. Toxicology 1985;34:139-51.
143. Marom Z, Shelhamer JH, Sun F, Kaliner M. Human airway monohydroxyeicosatetraenoic acid generation and release. J Clin Invest 1983;72:122-7.
144. Enss ML, Wagner S, Schmidt-Wittig U, Heim HK, Beil W, Hedrich HJ. Effects of PGE2 on amount and composition of high molecular weight glycoproteins released by human gastric mucous cells in primary culture. Prostaglandins Leukot Essent Fatty Acids 1997;56:93-8.
145. Shao MX, Nakanaga T, Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 2004;287:L420-7.
146. Lam CW, Casanova M, Heck HD. Depletion of nasal mucosal glutathione by acrolein and enhancement of formaldehyde-induced DNA-protein cross-linking by simultaneous exposure to acrolein. Arch Toxicol 1985;58:67-71.
147. Grafstrom RC, Dypbukt JM, Willey JC, et al. Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res 1988;48:1717-21.
148. Mitchell DY, Petersen DR. Inhibition of rat liver aldehyde dehydrogenases by acrolein. Drug Metab Dispos 1988;16:37-42.
149. Cooper KO, Witz G, Witmer C. The effects of alpha, beta-unsaturated aldehydes on hepatic thiols and thiol-containing enzymes. Fundam Appl Toxicol 1992;19:343-9.
150. Bergelson S, Pinkus R, Daniel V. Induction of AP-1 (Fos/Jun) by chemical agents mediates activation of glutathione S-transferase and quinone reductase gene expression. Oncogene 1994;9:565-7.
151. Rogers DF, Jeffery PK. Inhibition of cigarette smoke-induced airway secretory cell hyperplasia by indomethacin, dexamethasone, prednisolone, or hydrocortisone in the rat. Exp Lung Res 1986;10:285-98.
152. Li Y, Martin LD, Spizz G, Adler KB. MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J Biol Chem 2001;276:40982-90.
153. Singer M, Martin LD, Vargaftig BB, et al. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 2004;10:193-6.